ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Davisite
|
552 |
214K |
22 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
552
|
214K
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
65 |
19/07/24 |
19/07/24 |
General
|
11K
|
4.0M
|
65
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
22K |
7.7M |
33 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
22K
|
7.7M
|
33
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
10 |
18/07/24 |
18/07/24 |
General
|
11K
|
4.0M
|
10
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
16 |
18/07/24 |
18/07/24 |
General
|
11K
|
4.0M
|
16
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
44 |
18/07/24 |
18/07/24 |
General
|
11K
|
4.0M
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
44K |
26 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
44K
|
26
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
32 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
32
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
38 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
38
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
11 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
30 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
30
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
33 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
44K |
59 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
44K
|
59
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
44K |
31 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
44K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
44K |
20 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
44K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
44K |
26 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
44K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
44K |
32 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
44K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
44K |
72 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
44K
|
72
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
38 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
168
|
47K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
40 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
168
|
47K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
42 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
81K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
35 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
81K
|
35
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
66 |
09/07/24 |
09/07/24 |
General
|
11K
|
4.0M
|
66
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
28 |
09/07/24 |
09/07/24 |
General
|
11K
|
4.0M
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
40 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
81K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
24 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
81K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
58 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
81K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
29 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
81K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
44 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
81K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
21 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
81K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Davisite
|
905 |
269K |
37 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
905
|
269K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
38 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
81K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
81K |
34 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
81K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
19 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
168
|
47K
|
19
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Change of Director's Interest Notice - Peter Molloy
|
|
Davisite
|
4 |
2.5K |
11 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
4
|
2.5K
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
30 |
05/07/24 |
05/07/24 |
General
|
11K
|
4.0M
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
42 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
42
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
25 |
05/07/24 |
05/07/24 |
General
|
11K
|
4.0M
|
25
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
4.0M |
84 |
05/07/24 |
05/07/24 |
General
|
11K
|
4.0M
|
84
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
19 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
51 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
84 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
84
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Davisite
|
130 |
37K |
43 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Davisite
|
130 |
37K |
13 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Davisite
|
130 |
37K |
67 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
67
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Davisite
|
130 |
37K |
14 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Davisite
|
130 |
37K |
61 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Davisite
|
130 |
37K |
58 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
58
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Davisite
|
86 |
32K |
15 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
32K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Davisite
|
130 |
37K |
42 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
42
|
|